To investigate lamivudine (LAM)-resistance profiles of hepatitis B virus (HBV) at the early stages of virological breakthrough (serum HBV-DNA 12-345IU/ml) or when HBV-DNA is undetectable.
Svicher, V., Alteri, C., Gori, C., Salpini, R., Marcuccilli, F., Bertoli, A., et al. (2010). Lamivudine-resistance mutations can be selected even at very low levels of hepatitis B viraemia. DIGESTIVE AND LIVER DISEASE, 42(12), 902-907 [10.1016/j.dld.2010.04.017].
Lamivudine-resistance mutations can be selected even at very low levels of hepatitis B viraemia
Svicher, V;Salpini, R;BERTOLI, ADA;ANGELICO, MARIO;CECCHERINI SILBERSTEIN, FRANCESCA;PERNO, CARLO FEDERICO
2010-12-01
Abstract
To investigate lamivudine (LAM)-resistance profiles of hepatitis B virus (HBV) at the early stages of virological breakthrough (serum HBV-DNA 12-345IU/ml) or when HBV-DNA is undetectable.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Questo articolo è pubblicato sotto una Licenza Licenza Creative Commons
